Miruvor
Sign up
The short answer

What studies of folinic acid (leucovorin) found

1paper on folinic acid (leucovorin)
42people in 1 study testing folinic acid (leucovorin) alone
0randomised trials, the strongest kind of study

At a glance, by condition

ME/CFS: C Might help, very uncertain

Based on the strongest evidence, studies with no comparison group (very low certainty), for overall symptoms.

1 outcome rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: Folinic acid (leucovorin) might help some people with ME/CFS, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects, the doses studied and all 1 paper.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. Folinic acid (leucovorin) · ME/CFS is hereC
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. D
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

ME/CFS

Daily life and health overall

Overall symptoms1 study · 42 people took folinic acid (leucovorin) Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (42 in all); not all results were tested against chance.

Studies with no comparison group58 in the study · 42 started · 42 with outcome data · 1−2 months · 25 mg dose level, 3−4 times daily for 1−2 months

Overall symptoms improved.

The evidence is very uncertain about the effect of folinic acid (leucovorin) on overall symptoms in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (42 in all)
  • Not all results were tested against chance
See the 1 study
  1. Clinical activity of folinic acid in patients with chronic fatigue syndrome. (2006)

    People in the study
    58 in the study · 42 started · 42 with outcome data
    Dose
    25 mg dose level, 3−4 times daily for 1−2 months
    Outcome
    improvement with increased energy level and reduced pain
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I

Side effects

No study of this treatment alone reported side effects we could read.

Doses studied

What researchers used, as the papers print it; not a recommendation.

  1. 1Start

    25 mg at the start

  2. 2Top dose

    Most often 25 mg (1 of 1 studies)

Doses across 1 study

25 to 25 mg.

Each study’s dose, as printed

All papers

  1. Clinical activity of folinic acid in patients with chronic fatigue syndrome.2006 · no comparison group · 58 in the study · 42 started · 42 with outcome data
    Summary

    This retrospective study evaluated 58 patients with chronic fatigue syndrome (CFS) at the Parker Hughes Institute and Parker Hughes Clinics, St. Paul, MN (USA). Forty-two patients were empirically treated with oral folinic acid at a 25 mg dose level 3−4 times daily for 1−2 months; patients were interviewed about effects on fatigue and pain. There was no comparison group. Within 2 months, 34 patients (81 %) reported significant subjective improvement with increased energy level and reduced pain. Table 4 reported improvement after folinic acid in 14 of 20 (70 %) with CFS or CFS plus FM, 6 of 8 (75 %) with CFS plus IBD, 8 of 8 (100 %) with CFS plus RA, 5 of 5 (100 %) with CFS plus SLE, 1 with CFS plus MS, 10 of 13 (77 %) with EA IgG−, and 24 of 29 (83 %) with EA IgG+. Several patients also reported improvement in numbness of their hands and feet. No patient reported side effects from folinic acid. The paper does not report withdrawals for harms, worsening, or stopping treatment. The authors state that folic acid deficiency was not examined using serum folate measurements.

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime